Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 1 of the 24 sources its claims cite were checked for support.
Abstract
Epigenetic modifiers have fundamental roles in defining unique cellular identity through the establishment and maintenance of lineage-specific chromatin and methylation status. Several DNA modifications such as 5-hydroxymethylcytosine (5hmC) are catalysed by the ten eleven translocation (Tet) methylcytosine dioxygenase family members, and the roles of Tet proteins in regulating chromatin architecture and gene transcription independently of DNA methylation have been gradually uncovered. However, the regulation of immunity and inflammation by Tet proteins independent of their role in modulating DNA methylation remains largely unknown. Here we show that Tet2 selectively mediates active repression of interleukin-6 (IL-6) transcription during inflammation resolution in innate myeloid cells, including dendritic cells and macrophages. Loss of Tet2 resulted in the upregulation of several inflammatory mediators, including IL-6, at late phase during the response to lipopolysaccharide challenge. Tet2-deficient mice were more susceptible to endotoxin shock and dextran-sulfate-sodium-induced colitis, displaying a more severe inflammatory phenotype and increased IL-6 production compared to wild-type mice. IκBζ, an IL-6-specific transcription factor, mediated specific targeting of Tet2 to the Il6 promoter, further indicating opposite regulatory roles of IκBζ at initial and resolution phases of inflammation. For the repression mechanism, independent of DNA methylation and hydroxymethylation, Tet2 recruited Hdac2 and repressed transcription of Il6 via histone deacetylation. We provide mechanistic evidence for the gene-specific transcription repression activity of Tet2 via histone deacetylation and for the prevention of constant transcription activation at the chromatin level for resolving inflammation.
Overview
CoChat Summary
TL;DR
Tet2 actively represses Il6 transcription during the late phase of LPS-driven inflammation in myeloid cells by recruiting Hdac2 to the Il6 promoter, independent of DNA methylation. Tet2 loss prolongs IL-6 production and worsens endotoxin shock and DSS-induced colitis in mice.
Key findings
- In Tet2-deficient or Tet2-silenced dendritic cells and macrophages, the early LPS-induced rise in Il6 mRNA before 4 h was largely unchanged, but after 8 h Il6 mRNA remained elevated while control cells declined; IL-6 protein also increased, whereas Tnfa levels were similar. Tet3 silencing barely affected Il6.
- Tet2-deficient mice produced more IL-6 after systemic LPS, especially late, and showed worse lung tissue damage; in DSS colitis they had greater weight loss, higher IL-6, more inflammatory cell infiltration, and mucosal disruption. In Tet2-deficient BMDC, 22 genes were downregulated and 13 upregulated; 12 of the upregulated genes were TLR-induced, including Il6.
- IκBζ interacted with Tet2 and was required for Tet2 binding to the Il6 promoter at late LPS phase. IκBζ overexpression increased Il6 early but reduced it late, and Tet2 loss impaired this late repression.
- Tet2 associated with Hdac1/Hdac2 through its core-DSBH domain. Hdac2 binding at the Il6 promoter fell early and returned late; Hdac2 knockdown increased Il6 transcription and histone acetylation at 10 h, with Hdac1 compensation by 12 h. Catalytically mutant Tet2 still repressed Il6, and Tet2 loss reduced Hdac2 binding and late histone deacetylation.
Methods
- Mouse models included C57BL/6, Tet2fl/fl, Tet2-deficient, and Lyz2-Cre myeloid-specific Tet2-deficient mice; human monocytes came from healthy donors. Cells studied included BMDC, BMM, peritoneal macrophages, and splenic T, B, and NK cells, with LPS at 100 ng/ml; in vivo models were endotoxin shock and DSS colitis.
- Assays included RNA-seq, qPCR, ELISA, immunoblot, immunoprecipitation, co-IP with LC-MS/MS, ChIP and re-ChIP, luciferase reporters, siRNA knockdown, overexpression, and a GAL4-based recruitment assay.
- Statistics used unpaired Student’s t-tests with *P < 0.05 and P < 0.01; error bars were s.e.m. or s.d.; data were from triplicate technical or biological replicates and representative of three independent experiments.
Limitations
- The paper states that animal studies did not randomize by weight or sex and did not use blinding, and that sample size was not predetermined by a statistical method. It also states that HEK293T cells were not authenticated or tested for mycoplasma.
- Evident from the text: Hdac2 knockdown effects were transient because Hdac1 appeared to compensate by 12 h, complicating conclusions about Hdac2-specific repression.
- Evident from the text: many mechanistic experiments relied on overexpression or siRNA in HEK293T or primary cells, and the in vivo work used two inflammatory models; the authors note that additional Tet2-repressed mediators may exist in tissue-resident immune cells.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 16 Not checked · 86 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“MS-275 strongly inhibits Hdac1/2 over Hdac3 (ref. 19)”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
What the sources say
- Supportedcites [19] Inoue S Mai A Dyer MJ Cohen GM Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 2006 66 6785 6792 16818655 source
In the Results section 'Expression of HDACs in CLL cells and various cell lines', our copy reports that MS-275 (1-2.5 micromol/L) inhibited HDAC1 and HDAC2 activities by ~50-70% whereas 1 micromol/L did not inhibit HDAC3 (~20% only at 2.5 micromol/L), and explicitly frames the experiment as confirming that 'MS-275 was selectively inhibiting HDAC1 and HDAC2 rather than HDAC3'. The same section also states MS-275 preferentially inhibits HDAC1 (IC50 ~0.3 micromol/L) versus HDAC3 (IC50 ~8 micromol/L), though that IC50 comparison is itself credited to ref. 32; the paper's own immunoprecipitation/activity data carry the claim. Thus the paraphrase 'strongly inhibits Hdac1/2 over Hdac3' matches what this source attributes to MS-275. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“overexpressed Tet2 recruited more endogenous Hdac2 to the Il6 promoter”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Attenuated histone deacetylation in Tet2-deficient cells was also observed at late phase during LPS response”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“loss of Tet2 caused higher expression of IFN-γ in activated CD8+ T cells”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Loss of Tet2 barely affects TLR4 signalling pathways”
§ Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 > Extended Data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
45 more claims
Create a free account to see all 103 claims and to verify the 15 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 28
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mice deficient in Tet2 developed more severe inflammation in several tissues upon challenge with bacterial endotoxin”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this effect on Il6 expression was independent of the catalytic function of Tet2”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“loss of TET2, an enzyme that catalyzes DNA demethylation, results in prolonged and high expression of proinflammatory cytokines, including IL-6 [180].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [180]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As CHIP-associated mutations are known to alter the development and function of myeloid cells”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results contrast with findings in peripheral macrophages after intraperitoneal injection in vivo (Zhang et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Zhang et al., 2015
Experimental — accuracy not yet measured
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Ito, S., D’Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., & Zhang, Y. (2010) · Nature · doi:10.1038/nature09303 · Cited by 2,373
TET enzymes, TDG and the dynamics of DNA demethylation
Kohli, R. M., & Zhang, Y. (2013) · Nature · doi:10.1038/nature12750 · Cited by 1,623
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
Gene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Self-citationImpaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,213
Distinct Effects of T-bet in T H 1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T Cells
Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P., & Glimcher, L. H. (2002) · Science · doi:10.1126/science.1065543 · Cited by 1,172
Cited by
Items 501–600 of 797
The role of clonal haematopoiesis in cardiovascular diseases: epidemiology and experimental studies
Min, K. D., Kour, A., Sano, S., & Walsh, K. X. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13130 · Cited by 12
Transcriptomic analysis of the oviduct of pigs during the peri-conceptional period
Martyniak, M., Zglejc‐Waszak, K., Franczak, A., & Kotwica, G. (2018) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2018.08.040 · Cited by 12
Jin, M., Ji, J., Chen, X., Zhou, Y. Y., Wang, D., & Liu, A.-X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1066599 · Cited by 12
“TET2-KO macrophages and DCs produce more proinflammatory cytokines, such as IL-6, in response to bacterial activation (43, 73).”
BackgroundResultSuehara, Y., Sakamoto, K., Fujisawa, M., Fukumoto, K., Abe, Y., Makishima, K., Suma, S., Sakamoto, T., Hattori, K., Sugio, T., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02563-0 · Cited by 15
DNA (Hydroxy)Methylation in T Helper Lymphocytes
Monticelli, S. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.01.009 · Cited by 12
“Moreover, in myeloid cells TET2 was shown to repress transcription of the Il6 gene via recruitment of HDAC2 and histone deacetylation [66].”
BackgroundProtein C-ets-2 epigenetically suppresses TLRs-induced interleukin 6 production in macrophages
Zhao, J., Huang, K., Peng, H.-Z., & Feng, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.123 · Cited by 11
Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease
Jung, C. H., Evans, M. A., & Walsh, K. X. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000726 · Cited by 12
“On the other hand, it has also been shown that TET2 can promote the transcriptional repression of genes by recruiting histone deacetylases (HDAC) to gene promoter regions [25,28].”
BackgroundTET2 Regulates 5-Hydroxymethylcytosine Signature and CD4+ T-Cell Balance in Allergic Rhinitis
Tan, L., Fu, L., Zheng, L., Fan, W., Tan, H., Tao, Z., & Xu, Y. (2022) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2022.14.2.254 · Cited by 11
Mangaonkar, A. A., & Patnaik, M. M. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2056175 · Cited by 11
The epigenetic regulation of the germinal center response
Wu, S., Yin, Y., & Wang, X. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194828 · Cited by 12
Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease
Liu, H., Xie, Y., Wang, X., Abboud, M. I., Ma, C., Ge, W., & Schofield, C. J. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12733 · Cited by 14
Self-citationYang, F., Liang, W., Yang, X., Yuan, R., & Zhuo, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03667 · Cited by 11
Clinical and Therapeutic Implications of Clonal Hematopoiesis
Petrone, G. E. M., Turker, I., Natarajan, P., & Bolton, K. L. (2024) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120722-100409 · Cited by 12
Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Kapoor, S., Champion, G., Basu, A., Mariampillai, A., & Olnes, M. J. (2021) · Cancers · doi:10.3390/cancers13195026 · Cited by 14
“Inflammasome signaling in the MDS marrow is amplified by mutations in genes encoding DNA (cytosine-5) methyltransferase 3A (DNMT3A) and Ten-eleven translocation 2 (TET2), which diminish their ability to quell inflammation through increased production of interferon-α and β, and upregulation of IL-6 through epigenetic r…”
BackgroundElbæk, M. V., Sørensen, A. L., & Hasselbalch, H. C. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3489-0 · Cited by 12
Wang, D., Yang, Y., Cao, Y., Meng, M., Wang, X., Zhang, Z., Fu, W., Duan, S., & Tang, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-38848-6 · Cited by 15
“In particular, HDAC2 is a vital epigenetic regulator of gene expression in cancer [15] .”
Vasileva, F., Hristovski, R., Font‐Lladó, R., Georgiev, G., Sacot, A., López‐Ros, V., Calleja-González, J., Barretina, J., López‐Bermejo, A., & Prats‐Puig, A. (2023) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000004686 · Cited by 13
Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α
Liu, B., Xie, D., Huang, X., Jin, S., Dai, Y., Sun, X., Li, D., Bennett, A. M., Diano, S., & Huang, Y. (2024) · Diabetologia · doi:10.1007/s00125-023-06073-5 · Cited by 11
“Despite the importance of TETs in development, cancer, stem cells and immunity [20, 24, 25, 29–33], their roles in energy metabolism have just begun to be recognised, as exemplified by a few recent publications [27, 28, 34–36].”
BackgroundWang, Q., Ma, C., Mao, H., & Wang, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134580 · Cited by 12
Ben-Crentsil, N. A., Ismail, W. M., Balasis, M. E., Newman, H., Quintana, A., Binder, M., Kruer, T. L., Neupane, S., Ferrall‐Fairbanks, M. C., Fernandez, J. A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0093 · Cited by 10
The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy
Verdonschot, J. A. J., Fuster, J. J., Walsh, K. X., & Heymans, S. R. B. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae682 · Cited by 14
Fu, H., Gao, B., Zhou, X., Hao, Y., Liu, C., Lan, A., Tang, J., & Zhou, F. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00739-1 · Cited by 11
“Previous research has demonstrated the multifaceted role of TET2 in regulating hematopoiesis [19], inflammation [21–26] G The protein expression level of VE-cadherin under silencing ITGA10 was measured by immunoblot.”
Kolb, A., Kulis-Mandic, A.-M., Klein, M., Stastny, A., Haist, M., Votteler, V., Weidenthaler‐Barth, B., Sinnberg, T. W., Sucker, A., Allies, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60929-5 · Cited by 11
Patnaik, M. M., Lasho, T. L., Padron, E., McCullough, K. B., Al‐Kali, A., Tefferi, A., Zeidan, A. M., Gangat, N., Savona, M. R., Steensma, D. P., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.25853 · Cited by 10
EnvIRONmental Aspects in Myelodysplastic Syndrome
Petzer, V., Theurl, I., Weiß, G., & Wolf, D. G. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105202 · Cited by 10
Różalski, R., Gackowski, D., Skalska-Bugała, A., Starczak, M., Siomek, A., Zarakowska, E., Modrzejewska, M., Dziaman, T., Szpila, A., Linowiecka, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00880-9 · Cited by 10
The TET-Sall4-BMP regulatory axis controls craniofacial cartilage development
Wang, W., Yang, N., Wang, L., Zhu, Y., Chu, X., Xu, W., Li, Y., Xu, Y., Gao, L., Zhang, B., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113873 · Cited by 15
Roles of HDACs in the Responses of Innate Immune Cells and as Targets in Inflammatory Diseases
Hu, Y., & Suliman, B. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_4 · Cited by 12
Frentzel, S., Katsoulis‐Dimitriou, K., Jeron, A., Schmitz, I., & Bruder, D. (2019) · European Journal of Immunology · doi:10.1002/eji.201847961 · Cited by 10
Clonal haematopoiesis of emerging significance
Hammond, D. E., & Loghavi, S. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.005 · Cited by 11
Baba, Y., Saito, B., Shimada, S., Sasaki, Y., Fujiwara, S., Arai, N., Kawaguchi, Y., Kabasawa, N., Tsukamoto, H., Uto, Y., et al. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03187-7 · Cited by 10
“Another study with an experimental mouse model has shown the anti-inflammatory function of Tet2 [18], and its associated mutation is frequently found in clonal hematopoiesis in MDS [19].”
BackgroundSalybekov, A. A., Wolfien, M., Kobayashi, S., Steinhoff, G., & Asahara, T. (2021) · Cells · doi:10.3390/cells10123266 · Cited by 10
“The enhanced levels of pro-inflammatory cytokines maintain mutant hematopoietic stem/progenitor cell survival and growth as they inhibit the HDAC2-mediated suppression of IL-6 transcription or upregulate a novel anti-apoptotic long, non-coding RNA (Figure 1) [82,83].”
BackgroundTET mediated epigenetic regulation of iNKT cell lineage fate choice and function
Tsagaratou, A. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.08.020 · Cited by 11
Bauer, M., Vaxevanis, C., Al‐Ali, H. K., Jaekel, N., Naumann, C. L. H., Schaffrath, J., Rau, A., Seliger, B., & Wickenhauser, C. (2021) · Cancers · doi:10.3390/cancers13020186 · Cited by 11
“Since most of the mutations identified alter the adaptive rather than the innate immune signaling, we conclude that the presence of T and B/plasma cell subpopulations in close proximity to CD34+ blasts in MDS and sAML is independent of the mutation induced neoantigens associated with immune modulatory mechanisms [34,4…”
BackgroundDiagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
Simoni, Y., & Chapuis, N. (2022) · Diagnostics · doi:10.3390/diagnostics12071659 · Cited by 11
Impacts of epigenetic reprogramming on innate immunity
Fu, J., & Wang, Y. (2024) · Animal Nutriomics · doi:10.1017/anr.2024.9 · Cited by 10
Metabolite and nutrient regulation of macrophages in obesity and metabolic disease
Sprenkle, N. T., & Mills, E. L. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01292-4 · Cited by 15
“In the nucleus, succinate antagonizes Jumonji C domain-containing histone demethylases (JMJDs) and the TET family of DNA demethylases to remodel the epigenome, which can control inflammatory responses in macrophages 62,63 .”
Yu, L., Zeng, J., Luo, B., Li, W., He, Y., Zhao, W., Hu, N., Jiang, N., Luo, Y., Xian, Y., et al. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.08.003 · Cited by 11
Self-citationZhan, X., Zhou, H., Sun, Y., Shen, B., & Chou, D. (2021) · Clinics · doi:10.6061/clinics/2021/e2671 · Cited by 10
“Thus, it regulates gene expression by modifying histone marks and chromatin accessibility (13).”
BackgroundTen-Eleven Translocation Ablation Impairs Cardiac Differentiation of Mouse Embryonic Stem Cells
Fang, S., Cui, D., Hong, T., Guo, L., Lee, Y., Lee, M., Isgandarova, S., Martinez-Moczygemba, M., Zhou, Y., Li, J., et al. (2022) · Stem Cells · doi:10.1093/stmcls/sxab017 · Cited by 9
Yuan, S., Gao, Y., Xia, Y., Wang, Z., & Wang, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1008644 · Cited by 15
Threonine Phosphorylation of IκBζ Mediates Inhibition of Selective Proinflammatory Target Genes
Grondona, P., Bucher, P., Schmitt, A., Schönfeld, C., Streibl, B. I., Müller, A., Eßmann, F., Liberatori, S., Mohammed, S., Hennig, A., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.12.036 · Cited by 13
Moon, I., Kong, M. G., Ji, Y. S., Kim, S. H., Park, S. K., Suh, J., & Jang, M. (2022) · Annals of Laboratory Medicine · doi:10.3343/alm.2023.43.2.145 · Cited by 10
“Macrophages and dendritic cells derived from Tet2-deficient mice exhibited aberrant production of inflammatory cytokines, such as interleukin-6, when compared with wild-type cells [8].”
Li, F., Wu, X., Zhou, Q., & Zhu, D. W. X. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.04.001 · Cited by 10
CHIP-ping Away at Atherosclerosis
Keaney, J. F. (2017) · New England Journal of Medicine · doi:10.1056/nejme1706173 · Cited by 11
Sperotto, A. A., Bochicchio, M. T., Simonetti, G., Buccisano, F., Peccatori, J., Piemontese, S., Calistri, E., Ciotti, G., Pierdomenico, E., Marchi, R. D., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020359 · Cited by 10
HDAC inhibitors and IBD: Charting new approaches in disease management
Du, X., Yu, W., Chen, F., Jin, X., Xue, L., Zhang, Y., Wu, Q., & Tong, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114193 · Cited by 8
He, D., Ma, J., Zhou, Z., Qi, Y., Lian, Y., Wang, F., Yin, H., Zhang, H., Zhang, T., & Huang, H. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186673 · Cited by 13
“In line with our study, a previous study revealed that TET2 can repress gene transcription in chromatin not by its catalytic activity, but by interacting with histone deacetylase complexes (36).”
Clonal hematopoiesis of indeterminate potential and risk of immune thrombocytopenia
Liu, Q., Wästerlid, T., Smedby, K. E. E., Xue, H., Boberg, E., Fang, F., & Liu, X. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20092 · Cited by 12
TET3 is a common epigenetic immunomodulator of pathogenic macrophages
Liu, B., Dai, Y., Wang, Z., Song, J., Du, Y., Lv, H., Bellone, S., Yang, Y.-H., Kennedy, A. J., Zhang, S., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci194879 · Cited by 12
“Our results are in apparent contrast with several elegant studies indicating that macrophage TET2 functions in a divergent manner to restrain the expression of proinflammatory cytokines and chemokines (4, 7, 35, 36, 43, 53, 58–60).”
InfluentialSelf-citationHomeostatic maturation programs drive human cDC2s into a tolerogenic state
Lu, M., Han, R. H., Yang, H. Y., Yang, L., Zhao, Q., Wang, J., Yu, Z., Liu, N. K., Xu, Y., Luo, F., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.01.028 · Cited by 11
Self-citationChokeberry reduces inflammation in human preadipocytes
Brunelle, D. C., Larson, K., Bundy, A. N., Roemmich, J. N., Warne, D. K., & Redvers, N. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105947 · Cited by 9
“Research using Chromatin Immunoprecipitation (ChIP) has been used to determine acetylation of histone H3 specific to the IL-6 promoter (Wada et al., 2014; Hu et al., 2017; Zhang et al., 2015).”
BackgroundMethodHistone deacetylase in inflammatory bowel disease: novel insights
Li, C., Gu, S., Zhang, Y., Zhang, Z., Wang, J., Gao, T., Zhong, K., Shan, K., Ye, G., Ke, Y., et al. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251318833 · Cited by 13
Hu, Y., Yan, F., Ying, L., & Xu, D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_3 · Cited by 8
CHIPping away at Erdheim-Chester disease
Goyal, G. (2021) · Blood · doi:10.1182/blood.2020008965 · Cited by 8
Kumari, A., Bhawal, S., Kapila, S., & Kapila, R. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03027-0 · Cited by 8
“coli followed by a reduction in expression is also in agreement with the previous study where the transcription of this gene increased at 4 h of incubation with LPS followed by a suppressed expression in human and mice dendritic and myeloid cells (Zhang et al. 2015) respectively.”
ResultSelective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling
Šimelis, K., Saraç, H., Salah, E., Nishio, K., McAllister, T. E., Corner, T. P., Tumber, A., Belle, R., Schofield, C. J., Suga, H., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117597 · Cited by 8
Clonal hematopoiesis, aging and Alzheimer’s disease
Sánchez Vela, P., Trowbridge, J. J., & Levine, R. L. (2023) · Nature Medicine · doi:10.1038/s41591-023-02406-4 · Cited by 8
Self-citationUnderstanding the role of ten-eleven translocation family proteins in kidney diseases
Zhang, Y., Li, J., Tan, L., Xue, J., & Shi, Y. G. (2024) · Biochemical Society Transactions · doi:10.1042/bst20240291 · Cited by 8
The RNA-binding protein RRP1 brakes macrophage one-carbon metabolism to suppress autoinflammation
Zhou, Y.-M., Li, M., Jin, K., Wen, M., Qin, H., Xu, Y., Wang, C., Zhang, X., & Cao, X. (2025) · Nature Communications · doi:10.1038/s41467-025-62173-3 · Cited by 9
Self-citationLiu, Y., Zhang, P., Kong, W., Li, J., Yang, H., Bai, H., Fan, G., Cao, X., & Li, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1767601 · Cited by 10
Self-citationInhibition of DNA methylation attenuates lung ischemia–reperfusion injury after lung transplantation
Liu, M., Ju, Y., Jia, B.-W., Sun, X., Qiu, L., Liu, H.-Y., Xu, G., Tai, Q., Tan, J. H., & Gao, W. (2023) · Journal of International Medical Research · doi:10.1177/03000605231153587 · Cited by 8
Correlation of DNA methylation of DNMT3A and TET2 with oral squamous cell carcinoma
Li, X., Li, Z., Gao, Q., Peng, Y., Yu, Y., Hu, T., & Wang, W. (2024) · Discover Oncology · doi:10.1007/s12672-024-00866-9 · Cited by 8
Self-citationEpigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection
Krause, C., Bergmann, E., & Schmidt, S. V. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09266-2 · Cited by 8
“Interestingly, TET2 also has an important function in suppressing the expression of pro-inflammatory cytokines such as IL-6, IL-1β and ARG1 in macrophages [37].”
BackgroundMetabolic Adaptations and Functional Activity of Macrophages in Homeostasis and Inflammation
Yurakova, T. R., Gorshkova, E. A., Nosenko, M. A., & Drutskaya, M. S. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050043 · Cited by 10
“…in the medium or inhibition of glutaminase by its selective blocker bis-2-(5-phenylacetamido-1,3,4-thiadi-azole-2-diyl) ethyl sulfide (BPTES) during macrophage activation by LPS prevents the development of endotoxin tolerance [90], similar being demonstrated in a mouse model of toxic shock [112].”
The Role of Somatic Mutations in Ischemic Stroke: CHIP’s Impact on Vascular Health
Kinzhebay, A., & Salybekov, A. A. (2025) · Neurology International · doi:10.3390/neurolint17020019 · Cited by 8
Epigenetic mechanisms involved in modulation of inflammatory diseases
Bayarsaihan, D. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000281 · Cited by 7
Park, J., An, H., Lim, J., Park, I. S., Kim, M., Kim, J. H., Kim, S. W., Koh, Y. I., Lee, E. Y., & Cheon, J. H. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03014-w · Cited by 8
“Furthermore, CHIP could contribute to chronic inflammation; for example, loss of ten eleven translocation-2 (TET2) upregulated inflammatory mediators, such as interleukin-6, in mouse colitis and mouse atherosclerosis models [4, 5].”
BackgroundAdvances in innate immune signaling: new activators and regulators
Liu, J., & Cao, X. (2016) · National Science Review · doi:10.1093/nsr/nww016 · Cited by 8
Self-citationA vicious interplay between genetic and environmental insults in the etiology of blood cancers
Migliaccio, A. R. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.12.004 · Cited by 8
“Loss of TET2 function thus impairs the ability of cells to activate affected genes, including those necessary to suppress the inflammatory response (32).”
BackgroundNew “programmers” in tissue macrophage activation
Aschenbrenner, A. C., & Schultze, J. L. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1943-9 · Cited by 7
Tet2 deficiency–induced expansion of monocyte-derived macrophages promotes liver fibrosis
Feng, J., Wu, B., Li, Y., Sun, P., Liu, Q., Xiao, Q., Cai, J.-B., Zheng, Y., Chen, H., Xu, Y., et al. (2026) · Journal of Experimental Medicine · doi:10.1084/jem.20251114 · Cited by 6
“It is worth noting that several previous studies—including those by Zhang et al. (2015), Cull et al. (2017), and Jiang et al. (2019)—have indeed documented a role for Tet2 in modulating Il-6 expression in immune cells.”
Self-citationZhan, L., Wang, H., Lv, K., Sui, L., Yuan, M., Ao, L., Chen, Q., Li, J., Tian, L., Liu, Z., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.041 · Cited by 7
Sharma, D., Malik, A., Locher, V., McGrath, S., Zabala, S., Grover, H., Ciszewski, C., Chen, L., Yang, D., Chiu, I. M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.012 · Cited by 7
Shi, Y., Feng, D., Zhou, J., Liu, L., Li, X., Yuan, Z., Wu, J., & Yao, H. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.010 · Cited by 10
Self-citationBeberapa pemikiran tentang pendidikan Islam / Hasan Langgung
Langgulung, H. (1980) · Cited by 311
Xu, C., Yang, L., Cheng, T., Wang, Z., Liu, C., & Shao, J. (2024) · Inflammation · doi:10.1007/s10753-024-02091-6 · Cited by 8
“NFKBIZ encoding IκBζ protein is crucially involved in the development and resolution phases of inflammation [39].”
Jin, Y., Rao, K., Zheng, J., Zhang, X., Luo, Y., & He, J. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae504 · Cited by 9
“Subsequently, moon-lighting functions of TET2 were gradually uncovered such as oxidation of mRNA or tRNA (11, 12) and recruiting Hdac2 to repress gene transcription (13).”
Self-citationPI3K-mediated Kif1a DNA methylation contributes to neuropathic pain: an in vivo study
Jiang, W., Yu, P., Yang, Y., Cai, M.-T., Gan, L., Qu, K., Cheng, Y., & Dong, M. (2025) · Pain · doi:10.1097/j.pain.0000000000003536 · Cited by 6
PJA2 Suppresses Colorectal Cancer Progression by Controlling HDAC2 Degradation and Stability
Chen, Z., Peng, C., Jin, C., Wang, Y., Wang, T., Yang, P., Peng, W., Sun, Q., Xu, H., Nie, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202401964 · Cited by 6
Clonal hematopoiesis of indeterminate potential and risk of autoimmune thyroid disease
Zhang, X. J., Wang, Y., Xue, H., Zhao, Y., Liu, M.-C., Wei, H., & Liu, Q. (2025) · BMC Medicine · doi:10.1186/s12916-025-04077-z · Cited by 8
Self-citationDupuy, H., Dussiau, C., Bidet, A., Sauvezie, M., de Grande, A., Decombe, J., Rivière, É., Forcade, É., Bonnet, F., Dumas, P., et al. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1973674 · Cited by 6
Awada, H. K., Bhatta, M., Yu, H., Ji, W., Hou, S., Cronin, T. L., Aqeel, S. B., Roy, A. M., Faisal, M. S., Kouides, P. A., et al. (2023) · Leukemia · doi:10.1038/s41375-023-02069-7 · Cited by 6
Clonal Hematopoiesis and Cardiovascular Risk: Atherosclerosis, Thrombosis, and beyond
Izzi, B., & Fuster, J. J. (2024) · Hämostaseologie · doi:10.1055/a-2219-6410 · Cited by 8
“43 Initial experimental evidence linking somatic TET2 mutations to atherosclerosis came from our research group, which demonstrated accelerated atherosclerosis in a mouse model of TET2 -mutant CHIP.”
BackgroundWhere There’s Smoke, There’s Fire: Inflammation Drives MDS
Datar, G. K., & Goodell, M. A. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.05.007 · Cited by 8
Zuriaga, M. A., & Fuster, J. J. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0505 · Cited by 6
Yegorov, Y. E., Poznyak, A. V., Bezsonov, E. E., Zhuravlev, A. D., Nikiforov, N. G., Vishnyakova, K. S., & Orekhov, A. N. (2022) · Biomedicines · doi:10.3390/biomedicines10040782 · Cited by 6
“The mechanism of action of TET2 mutations may consist of the suppression of the transcriptional activation of pro-inflammatory genes by TET2 via recruiting histone deacetylase 2 to the gene promoter [41].”
BackgroundMeng, L., Zou, Y., Shan, M., Zhang, M., Qi, R., Yu, Z.-M., Guo, P., Zheng, Q., & Gong, T. (2019) · Journal of International Medical Research · doi:10.1177/0300060519839625 · Cited by 6
“39,40 The present study had some limitations.”
Inflammatory Diseases and Risk of Atherosclerotic Cardiovascular Disease: A New Focus on Prevention
Quispe, R., Varghese, B. T., & Michos, E. D. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_13 · Cited by 7
The Immunological Consequences of Clonal Hematopoiesis in Heart Failure
Evans, M. A., & Walsh, K. X. (2026) · Immunological Reviews · doi:10.1111/imr.70094 · Cited by 7
Obrębski, T., Maleszewska, M., Dunin-Horkawicz, S., & Malik, A. R. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111267 · Cited by 6
“Another study, however, showed no alterations in Tnf expression levels in TET2-deficient LPS-stimulated murine BM-derived dendritic cells, BMDMs, and PMs, or in vivo in the blood serum of mice injected with LPS (26).”
InfluentialYanagisawa, H., Kawabata, H., Ueda, Y., Arita, K., Iwao, H. K., Sakai, T., Kawanami, T., Yamada, K., Mizuta, S., Fukushima, T., et al. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03321-z · Cited by 6
“Loss of Tet2, a product of commonly mutated gene in patients with MDS, was shown to augment IL-6 transcription during inflammation resolution in innate myeloid cells in mice [36].”
BackgroundSalybekov, A. A., & Hassanpour, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082288 · Cited by 6
“Third, not all the mutated CHIP genes promote synthesis of inflammationrelated factors, like IL-1β and IL-6.”
BackgroundInfluentialThe TET3 inflammasome senses unique long HSV-1 proteins for virus particle budding from the nucleus
Liu, Q., Li, W., Qian, Y., Wang, C., Kong, C., Li, M., Sun, L., Sun, L., Pang, Y., Jiang, C., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01221-2 · Cited by 6
Self-citationClonal Hematopoiesis in Women With Breast Cancer
Mayerhofer, C., Freedman, R. A., Parsons, H. A., Partridge, A. H., & Miller, P. G. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-01848 · Cited by 7
Jenkins, M. T., Chu, Y. E., Franceski, A. M., Potts, C. R., Dubin, R., Dickerson, K. M., Lee, S. C.-W., Lu, R., Welner, R. S., & Ferrell, P. B. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104727 · Cited by 5
Zhang, J. G., Zhou, C., Yu, G., Zhang, X., Ma, K., Peng, Z.-R., Luo, X.-Y., Liu, Z., Lin, X., Chen, W., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144179 · Cited by 5
Self-citationTarget practice: Opportunities for therapeutic intervention in CHIP and CCUS
Mohammad, A., Mascarenhas, J. O., Marcellino, B. K., & Nathan, D. I. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101323 · Cited by 5
Huang, Z., Wei, P., Gan, L., Li, W., Zeng, T., Qin, C., Chen, Z., & Liu, G. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9872 · Cited by 6
“HDAC2, a subtype of class I HDACs, is located in the nucleus and is primarily involved in the inhibition of inflammation (7,8).”
BackgroundCocco, G., & Amiet, P. (2021) · OBM Genetics · doi:10.21926/obm.genet.2103133 · Cited by 7
Metadata
- Authors
- Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., Su, X., Liu, J., Ge, W., Levine, R. L., Li, N., & Cao, X.
- Affiliations
- Second Military Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Cao, Xuetao
- ORCID
- Venue
- Nature
- Published
- 2015-08-19
- Volume
- 525
- Issue
- 7569
- Pages
- 389-393
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4697747
- OpenAlex
- W1171241794
- Cited by
- 807
- References
- 30
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 83 · 2023: 89 · 2022: 93 · 2021: 82 · 2020: 79 · 2019: 85 · 2018: 62 · 2017: 50 · 2016: 43 · 2015: 7
- FWCI
- 23.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA173636, P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TET2, HDAC2, interleukin-6, inflammation resolution, histone deacetylation, transcriptional repression, 5-hydroxymethylcytosine, IκB, lipopolysaccharide, dendritic cells, macrophages, endotoxic shock, DSS-induced colitis
- MeSH terms
- Interleukin-6 Inhibitors, Acetylation, Animals, Chromatin, Colitis, Dendritic Cells, DNA-Binding Proteins, Female, Histones, Humans, Inflammation, Macrophages, Male, Mice, Inbred C57BL, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription, Genetic, Down-Regulation, Interleukin-6, DNA Methylation, I-kappa B Proteins, Epigenesis, Genetic, Dioxygenases, Mice, Histone Deacetylase 2, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.